KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Short-term Investments (2016 - 2025)

Cvs Health's Short-term Investments history spans 17 years, with the latest figure at $2.1 billion for Q4 2025.

  • For the quarter ending Q4 2025, Short-term Investments fell 10.88% year-over-year to $2.1 billion, compared with a TTM value of $2.1 billion through Dec 2025, down 10.88%, and an annual FY2025 reading of $2.1 billion, down 10.88% over the prior year.
  • Short-term Investments for Q4 2025 was $2.1 billion at Cvs Health, up from $2.1 billion in the prior quarter.
  • The five-year high for Short-term Investments was $3.8 billion in Q2 2024, with the low at $2.1 billion in Q3 2025.
  • Average Short-term Investments over 5 years is $2.9 billion, with a median of $3.0 billion recorded in 2021.
  • Year-over-year, Short-term Investments increased 21.92% in 2024 and then plummeted 36.46% in 2025.
  • Tracing CVS's Short-term Investments over 5 years: stood at $3.1 billion in 2021, then dropped by 10.88% to $2.8 billion in 2022, then grew by 17.31% to $3.3 billion in 2023, then decreased by 26.14% to $2.4 billion in 2024, then fell by 10.88% to $2.1 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Short-term Investments are $2.1 billion (Q4 2025), $2.1 billion (Q3 2025), and $2.4 billion (Q2 2025).